Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Automatic Data Processing

Carlisle Companies

Dover

Vanguard Extended Duration Treasury ETF

General Dynamics

Jack Henry & Associates

KFA Mount Lucas Index Strategy ETF

Nordson

Polaris

Philip Morris

SEI Investments

T. Rowe Price Group

The economic data is getting worse at an accelerating rate. It now appears a 1.7% GDP recession lasting nine months could start in 5 weeks. The eerie calm of the market is 100% driven by an AI bubble in the biggest tech stocks. A bubble that could end as soon as next Wed.

13 Blue-Chips For The Ultimate High-Yield Buffett-Style Dividend Aristocrat Portfolio

Rio Tinto plc Sponsored

Vale S.A.

Irrespective of age, investors love regular cash flows from their investments. Of course, young investors have a higher inclination towards risky ideas and hence are overweight growth stocks.

3 Stocks to Buy With a Dividend Yield of Over 7%

Altria presented a mixed earnings card for Q1'23 in April. However, the cigarette company reaffirmed its FY 2023 adjusted EPS outlook.

Altria: Low P/E Ratio, High Dividend Yield, Risk/Reward Looks Attractive

Lincoln National

Telephone and Data Systems

With the S&P 500 index yielding less than 2% on average right now, high-dividend stocks are still appealing to income investors. Interest rates are on the rise, but investors can still find stocks that have superior yields.

3 Ultra-High Dividend Stocks Yielding Over 8%

Newell Brands

Invesco S&P Ultra Dividend Revenue ETF

Simon Property Group

V.F.

Verizon

There are red flags with each of the five highest-yielding dividend stocks on the S&P 500. A better option is an ETF that screens for the top dividend yields and lowest payout ratios.

Should You Buy the 5 Highest-Paying Dividend Stocks In the S&P 500?

Alliance Resource Partners

Energy Transfer LP Unit

FS KKR Capital Corp

Starwood Property

Truist Financial

If you have ever heard the term “stock pickers market,” this is surely where investors find themselves now as we approach the end of the first half of 2023.

7 Buy-Rated Stocks With Dividends as High as 15% Are On Sale Now

Johnson & Johnson

In good times and bad, investors want the best dividend stocks for passive income. However, it's more than just Googling the top dividend names or biggest yields.

3 Bargain Dividend Stocks to Boost Your Passive Income

Altria remains a compelling investment opportunity for conservative income investors. It has control over its own destiny with a portfolio of reduced risk products.

Altria: The New Normal

SEATTLE--(BUSINESS WIRE)--Keller Rohrback is thrilled to announce a $235 million settlement with Altria and related companies, in the massive nation-wide JUUL e-cigarette youth vaping predatory advertising, fraud, addiction and injury litigation: In re JUUL Labs, Inc. Mktg., Sales Practices, & Prods. Liab. Litig., MDL No. 2913 (N.D. Cal.). Altria is the parent company of Philip Morris USA and the company behind Marlboro cigarettes. They were also one the major investors in the JUUL e-cigare.

Keller Rohrback L.L.P.: Altria Agrees in Principle to $235 Million Settlement in Nationwide JUUL E-Cigarette Youth Vaping Litigation

JPMorgan Equity Premium Income ETF

PIMCO Dynamic Income Opportunities Fund

SL Green Realty

Walgreens

The Dividend Harvesting Portfolio is now generating $953.75 in annual dividends, yielding 8.4%. The Dividend Harvesting portfolio has a 66.67% record of finishing the week in the black since its inception, 76/114 weeks.

Dividend Harvesting Portfolio Week 114 $11,400 Allocated, $953.75 In Projected Dividends

Cardinal Health

Chubb

Diageo

General Electric

GlaxoSmithKline

Illinois Tool Works

Johnson Controls

Kimberly-Clark

Coca-Cola

Leggett & Platt

Mondelez

Markets continue to look shaky, real estate is starting to crack, precious metals doing pretty well but are still manipulated well below true value and the crypto world has started to thaw but nowhere near mania mode, yet. These lows and uncertain times are when the real profits and income is generated for the future.

Dividend Portfolio Update: April 2023

As of December, Altria's share of Juul was valued at $250 million, down from $12.8 billion in 2018.

Marlboro maker Altria agrees to pay $235M to settle Juul-related cases

Tobacco company Altria Group Inc. MO said Wednesday it reached a settlement with the majority of lawsuits from Juul users. The company said it reached terms to settle 6,000 state and federal Juul-related cases for $235 million, and will report it as a one-time charge in the second quarter.

Marlboro parent Altria offers $235 million to settle 6,000 Juul-related lawsuits

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--Altria Announces Agreement to Resolve Vast Majority of JUUL-Related State and Federal Litigation.

Altria Announces Agreement to Resolve Vast Majority of JUUL-Related State and Federal Litigation

SAN FRANCISCO--(BUSINESS WIRE)--Plaintiffs' Co-Lead Counsel announce a comprehensive and historic $235 million settlement with Altria in the nationwide JUUL e-cigarette vaping predatory advertising, fraud, addiction and injury litigation currently facing bellwether trial in San Francisco. The settlement will resolve all remaining personal injury, consumer class action, and government entity cases brought in the national MDL and the JCCP in California against Altria (the earlier phase of the vas.

Girard Sharp and Co-Lead Counsel Announce $235 Million Comprehensive Settlement with Altria in National JUUL E-Cigarette Predatory Advertising, Addiction and Injury Cases

SAN FRANCISCO--(BUSINESS WIRE)-- #Altria--Lieff Cabraser Announces $235M Comprehensive Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction & Injury Cases.

Lieff Cabraser and Co-Lead Counsel Announce Historic $235M Comprehensive Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Cases

Apple

Comerica

JPMorgan Chase & Co

Carvana

DraftKings

Fisker Inc

Meme stocks comprise a wide spectrum of companies ranging from those sensible investors steer clear of, to firms with near-universal respect. This list of investment ideas sourced from here pulls primarily from the latter.

The 7 Best Meme Stocks to Buy for 2023

Cincinnati Financial

California Water Service Group

Gorman-Rupp

MSA Safety

PPG Industries

S&P Global

Stanley Black & Decker

Sysco

Tennant

The 49 Dividend Kings collectively were up 0.51% in April and continue their positive year-to-date return. The 12 best dividend kings selected for April, based on forecasted growth and valuation, outperformed the average dividend king return by 2.78%.

My 12 Best Dividend Kings For May 2023

MO's choice of acquiring NJOY is a prudent one, since the latter has obtained the necessary FDA marketing authorizations in the US. However, with NJOY's market share still underperforming compared to its vaping peers, it remains to be seen how much MO may need to spend to successfully market the product.

Altria: NJOY Likely A Moon Shot

News for Altria Stock (MO)